PURA ALERT - BUY Recommendation Issued Following Research Coverage Update With $0.25 PPS Target Confirmation
November 21 2018 - 8:39AM
InvestorsHub NewsWire
New
York, NY -- November 21, 2018 -- InvestorsHub NewsWire -- Puration,
Inc. (PURA)
received a BUY recommendation from AmericBulls.com after the Goldman Small Cap Research yesterday released an
update to its ongoing research coverage of PURA that confirmed
a Speculative BUY and $0.25 PPS Target PPS.
Americanbulls.com:
“Our
system’s recommendation today is to BUY. The BULLISH STOP
LOSS pattern finally received a confirmation because the
prices crossed above the Stop Loss level which was at 0.1089, and
our valid average buying price stands now at
0.1091.
A rally
after a bear setup can occasionally turn into an explosive long
trade. We may be on the verge of catching one of them. There is now
a strong positive sentiment in the market despite the absence of a
bullish pattern. The bullish stop loss is finally confirmed, and
a BUY signal is generated. The Market wants to reward the
bulls. It may be the right time to be part of this boost and
bullish market sentiment by joining the growing bullish
crowd.”
Goldman Small Cap
Research:
“PURA announced very strong 3Q18 results and the best is yet to
come. As a result, we believe that current prices represent a
terrific entry point for opportunistic investors. Moreover, we
expect PURA could return to its 52-week high of $0.25 early next
year, on the heels of products with new, upgraded packaging which
will begin reaching stores next week. PURA’s new package form is
priced at a convenient $20 per 4-pack. Management believes that
this new form will take sales to the next level.
We
believe our forecasts are conservative. For 2019, we
estimate sales will reach $3M, with operating profit of $800,000.
It should be noted that these figures exclude any contributions
from new products which are likely to be introduced in the coming
weeks. Separately, an under the radar
near-term catalyst is the pending dividend related to the
transaction with Nouveau Life Pharmaceuticals, (OTC - NOUV).
NOUV formally declared a 1:5 stock dividend whereby NOUV common
will be issued to PURA shareholders at a ratio of one NOUV common
share for every five shares of PURA held on the yet to be
determined date of record. Although this event is not
factored into the current stock price, we believe these shares
could rise ahead of the record date announcement.“
DISCLAIMER: NextBigTicker.com (NBT)is a third party publisher
and news dissemination service provider. NBT is NOT affiliated
in any manner with any company mentioned herein. NBT is news
dissemination solutions provider and are NOT a registered
broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security. NBT's
market updates, news alerts and corporate profiles are NOT a
solicitation or recommendation to buy, sell or hold securities. The
material in this release is intended to be strictly informational
and is NEVER to be construed or interpreted as research material.
All readers are strongly urged to perform research and due
diligence on their own and consult a licensed financial
professional before considering any level of investing in
stocks. All material included herein is republished content
and details which were previously disseminated by the companies
mentioned in this release or opinion of the writer. NBT is not
liable for any investment decisions by its readers or subscribers.
Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. NBT has not been
compensated for this release and HOLDS NO SHARES OF ANY
COMPANY NAMED IN THIS RELEASE.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur.
Source: www.nextbigticker.com
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Oct 2024 to Nov 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Nov 2023 to Nov 2024